MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.
View Top Employees from MPM BioImpactWebsite | http://www.mpmcapital.com/ |
Revenue | $6 million |
Employees | 68 (68 on RocketReach) |
Founded | 1996 |
Address | 399 Boylston St, Boston, Massachusetts 02116, US |
Phone | (617) 425-9200 |
Technologies |
JavaScript,
HTML,
PHP
+23 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Finance General, Biotechnology, Finance, Science and Engineering, Health Care, Life Science |
Web Rank | 7 Million |
Keywords | Mpm Capital, Sarah Reed Mpm, Dan Hicklin, "Mpm Capital", Burrage Capital Aum |
Competitors | Alta Partners, Domain Associates, HealthCare Ventures LLC, Pappas Capital, Versant Ventures |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular MPM BioImpact employee's phone or email?
The MPM BioImpact annual revenue was $6 million in 2024.
Todd Foley is the Managing Director of MPM BioImpact.
68 people are employed at MPM BioImpact.
MPM BioImpact is based in Boston, Massachusetts.
The NAICS codes for MPM BioImpact are [52, 5239, 523].
The SIC codes for MPM BioImpact are [679, 67].